This market will resolve based on Scribe Therapeutics' market capitalization at the closing price on its first day of trading.
As of market creation, the IPO is scheduled to price on July 24 (ET). If no such IPO occurs by August 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before September 2026".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency.
It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day.
If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently.
The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page.
If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket.
The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading.
In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.
<$85M
$352 Volume
2%
$85M-$100M
$307 Volume
2%
$100M-$115M
$312 Volume
2%
$115M-$130M
$366 Volume
2%
$130M-$145M
$367 Volume
3%
$145M+
$1.3K Volume
91%
No IPO before September 2026
$427 Volume
3%
Odds & FAQ
What are the current odds for Scribe Therapeutics IPO Closing Market Cap?
$145M+ dominates the field at 89%; the nearest challenger, $130M-$145M, trades at just 2%. The order book treats this as nearly decided.
What do traders predict for Scribe Therapeutics IPO Closing Market Cap?
With 89% implied for $145M+, the market has largely made up its mind. Still a forecast, not a result: prices react instantly if the story changes.
When does the Scribe Therapeutics IPO Closing Market Cap market resolve?
Resolution is scheduled for 24 Jul 2026 (1 days left). Once the outcome is confirmed, the market settles under Polymarket's published criteria.
How much money is trading on Scribe Therapeutics IPO Closing Market Cap?
$37.1K in total volume has traded here. Deeper markets like this tend to price events more sharply.
How can I trade Scribe Therapeutics IPO Closing Market Cap on Polymarket?
Follow this page for live prices; trading happens on Polymarket itself. Start small - implied odds move, and so can your position's value.
Similar Markets
December 31, 202617%YesNo
September 30, 20264%YesNo
↑ 1T yuan99%YesNo
↑ 1.5T yuan95%YesNo
December 31, 202670%YesNo
October 31, 202645%YesNo
400B+ yuan99%YesNo
370–400B yuan1%YesNo
December 31, 202749%YesNo
September 30, 202732%YesNo
$1.0T-$1.5T60%YesNo
$1.5T-$2.0T41%YesNo
$1.2B-$1.4B42%YesNo
$1B-$1.2B40%YesNo






